Updated Labeling for Menopausal Hormone Therapy

Why Doctors Hesitate to Say ‘I'm Sorry’ After Errors

Patient-Reported Skin Changes After GLP-1 Use Explored

Racial Differences in Adverse Events After Androgen Deprivation in Veterans With Prostate Cancer

WHO Warns of Surging Levels of Antibiotic Resistance

Perspectives on Managing Antibiotic Resistance

Common Painkillers May Accelerate Antibiotic Resistance, Study Warns

El PRAN celebra la jornada “Desmontando bulos, frenando resistencias” para promover el uso prudente de los antibióticos

La AEMPS refuerza la cooperación regulatoria en América Latina y el Caribe para avanzar hacia la autosuficiencia sanitaria

A Review on Emerging Technologies in Pharmaceutical Packaging: From Anti-Counterfeiting to Green Solutions

High-Engagement Social Media Posts Related to Prescription Drug Promotion for 3 Major Drug Classes

Boletín sobre Seguridad de Medicamentos de Uso Humano. Agosto y septiembre de 2025

FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies

Madrid suma 23 nuevas oficinas de farmacia a su red centinela para detectar problemas de seguridad con medicamentos

Retiran más de 140.000 frascos de un popular medicamento contra el colesterol alto

A Longitudinal Assessment of Greenhouse Gas Emissions From Inhaler Devices in a National Health System

Inhaler-Related Greenhouse Gas Emissions in the US. A Serial Cross-Sectional Analysis

GLP-1 Agonists Linked to Anorgasmia in a 71-Year-Old Woman

Incorporating Social Determinants of Health Into Clinical Practice Is Central to Improving Care and Outcomes

Real-World Evidence in Drug Approvals at the European Medicines Agency

Common OTC Sleep Aid Linked to Heart Failure Risk

The Off-Label Treatment That Helps Many With Fibromyalgia

Cannabis for Rheumatic Pain? Experts Call for More Evidence

Which Contraceptives Tied to Greater Breast Cancer Risk?

La AEMPS participará de nuevo en la #MedSafetyWeek, que celebra su décimo aniversario con el fin de promover la notificación de sospechas de reacciones adversas de medicamentos

Before, With, or After Meals? Why Pill Timing Matters

Cardiometabolic Effects of Antidepressants Vary Significantly

Opioid Abuse

Time to Reconsider Tramadol for Chronic Pain?

Systemic Drugs Associated With Maculopathy

Alternatives to Government-Imposed Price Controls to Lower US Drug Prices

Comparative Cancer Risk in Patients With Psoriasis Treated With Adalimumab, Secukinumab, or Ustekinumab

One in 6 Common Bacterial Infections Are Resistant to Antibiotics, WHO Warns

Principales enfermedades pediátricas con implicación farmacológica

Fatal Mix-Ups Spur EMA Warning on Tranexamic Acid Use

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non–Small-Cell Lung Cancer

Comparative Safety of JAK Inhibitors vs TNF Antagonists in Immune-Mediated Inflammatory Diseases. A Systematic Review and Meta-Analysis.

Serena Williams Sparks Debate Over GLP-1 Promotion

Nitrous Oxide Deaths: A Growing US Health Crisis?

EMA: Deworming Med Under Review for Brain Side Effects